{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24787433",
  "DateCompleted": {
    "Year": "2014",
    "Month": "12",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2217/nnm.14.6"
    ],
    "Journal": {
      "ISSN": "1748-6963",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "4",
        "PubDate": {
          "Year": "2014",
          "Month": "Apr"
        }
      },
      "Title": "Nanomedicine (London, England)",
      "ISOAbbreviation": "Nanomedicine (Lond)"
    },
    "ArticleTitle": "Exploiting cancer's antioxidative weakness through p53 with nanotoxicology.",
    "Pagination": {
      "StartPage": "369",
      "EndPage": "371",
      "MedlinePgn": "369-71"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical & Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, 117585 Singapore, Singapore."
          }
        ],
        "LastName": "Setyawati",
        "ForeName": "Magdiel Inggrid",
        "Initials": "MI"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tay",
        "ForeName": "Chor Yong",
        "Initials": "CY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Leong",
        "ForeName": "David Tai",
        "Initials": "DT"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nanomedicine (Lond)",
    "NlmUniqueID": "101278111",
    "ISSNLinking": "1743-5889"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Reactive Oxygen Species"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Tumor Suppressor Protein p53"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanomedicine"
    },
    {
      "QualifierName": [
        "metabolism",
        "therapeutic use"
      ],
      "DescriptorName": "Nanoparticles"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Reactive Oxygen Species"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Tumor Suppressor Protein p53"
    }
  ]
}